Advertisement
Advertisement
Advertisement
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Susan Hasty, Publisher
Table of Contents . . . September 24th, 2004
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Food & Drug Law Weekly | Other Publications
Arena Solutions, Inc. - Product Lifecycle Management solution available for device industry
AstraZeneca - FDA approves RHINOCORT AQUA for use in pregnant women
Bavarian Nordic - Progress reported in smallpox vaccine development
BioCryst Pharmaceuticals, Inc. - Orphan drug status granted for BCX-1777 in two additional cancer indications
Bioenvision, Inc. - New patient data generated in support of the clofarabine new drug application
Breast Cancer Internl. Res. Group - BCIRG 001 study is the basis for U.S. FDA approval of docetaxel
Bristol-Myers Squibb - Long-term data provides guidance on use of Sustiva in HIV treatment
Cardiovascular Care - Untested catheter used in trials of recalled stent
Cellegy Pharmaceuticals, Inc. - NDA for Cellegesic is accepted for review by U.S. FDA
Cyberonics, Inc. - VNS-focused company raises Q2 earnings guidance
Forest Laboratories, Inc. - Company submits response to U.S. FDA regarding Lexapro for panic disorder
Generic Drugs - Agency defers approval decision for Omnitrope
Genmab, A/S - HuMax-CD4 receives U.S. orphan drug designation
ILEX Oncology Inc. - New patient data to support clofarabine NDA for pediatric leukemia
Internal. Soc. for Pharmacoepidemiology - Risk of heart attack related to COX-2 inhibitors studied
Agile Therapeutics - Contraceptive patch maker closes $4.5M financing
Alba Therapeutics Corporation - Biopharmaceutical firm signs supply agreement with Solvay
Albert Einstein College of Medicine - Prevalence and diversity of M. tuberculosis arabinomannan reported
American Chiropractic Association - Chronic back pain sufferers prefer drug-free pain management, survey shows
Angina - Study shows no benefit from early PCI/CABG in high-risk unstable angina patients
Archet Hospital, Nice - Imatinib mesylate lowers VEGF levels in chronic myeloid leukemia patients
AstraZeneca LP - Ximelagatran does not interact with digoxin
Baxter Healthcare Corp. - Nanoparticle-formulation of drugs can be administered by several routes
Baylor Intl. Pediatric AIDS Initiative - HIV-positive children in resource-limited setting successfully treated
BioFocus plc - Drug discovery alliance to cover multiple targets
Bioenvision - European marketing approval sought for Clofarabine
Biovitrum - Promising oncology project acquired from Axelar
Boston Scientific Corporation - First patient enrolled in trial for paclitaxel-eluting coronary stent system
Bracco - Early findings suggest Isocolan is effective for constipation during pregnancy
Breast Cancer - Counseling boosts immunity, improves health habits
Breast Cancer - Not all women with breast cancer require psychosocial help
Business Update - Boston Scientific stent regains market share, despite August sales
Butler Hospital - ARICEPT may offer hope to those suffering from mild cognitive impairment
CV Therapeutics - Ranolazine study demonstrates important cardiac ion channel effects
ChemNavigator - LION bioscience enters key cheminformatics partnership
Children's Hospital of Philadelphia - Steroids may contribute to increased bone mass in nephritic syndrome patients
Chinese Academy of Science, Beijing - Poly(acrylic acid) inhibits HIV-1 TAR RNA-Tat peptide interaction
Chinese Academy of Sciences - Swelling behavior of alginate-chitosan microcapsules characterized
Columbia University - Gemtuzumab ozogamicin with cytarabine effective in elderly AML patients
Correctional Health - Officials say health contract was renewed in midst of jail deaths
Covalent Group, Inc. - CRO finalizes agreement for $9.7 million of new business
Crucell N.V. - PER.C6-produced HIV vaccine to advance to next phase of clinical trials
Curis, Inc. - Inhibitors of Hedgehog signaling pathway block growth of prostate cancer cells
DarPharma - DAR-0100 to be evaluated in trial for working memory deficits in schizophrenia
Dokuz Eylul University - Report describes upper extremity deep vein thrombosis
Drug Abuse - Alabama doctor starts 'Mothers Against Meth' after losing her own brother
Dynamarketing Group Inc. - New hangover remedy sparks controversy
Encysive Pharmaceuticals - Thelin data presented at the European Society of Cardiology annual congress
Finance - Misonix, Inc., reports record revenues and increased earnings
Flat-D Innovations, Inc. - Company introduces flatulence deodorizing pad
Fourth Military Medical University, Shaanxi - MAGE-n peptide could be immunotherapy target
Fred Hutchinson Cancer Research Center - Researchers uncover a key driver behind progression of prostate cancer
Fujita Health University - Dermatitis-like symptoms seen in HR-1 hairless mice on low magnesium/zinc diet
General Data Company, Inc. - Patient identification wristbands offers error-free bar code and photo ID
Gladstone Inst. of Virology & Immunology - Future of HIV therapeutics is brightening, says expert
Introgen Therapeutics, Inc. - Food, drug law expert joins biopharmaceutical company's board of directors
Kos Pharmaceuticals, Inc. - Positive results announced from inhaled insulin therapy phase IIa trial
Legal Issues - Federal judge reviews Mississippi hospital charity settlement case
Legal Issues - Hospital accused of overcharging uninsured
Lifeline Biotechnologies Inc. - Trinion Meniscus Screw for knee cartilage repair receives U.S. FDA clearance
Medtronic, Inc. - FDA approves left-heart lead for cardiac resynchronization therapy systems
OSI Pharmaceuticals, Inc. - Pharma company and Roche announce filing Tarceva with European Authorities
PerkinElmer Life and Analytical Sciences, Inc. - FDA clears new lab test to help screen newborn infants for congenital disease
Roche - Pharma company submits application to market Xeloda colon cancer treatment
Royal Holloway-University of London - Diversity in pathogenicity can cause outbreaks of meningococcal disease
Schering-Plough Corporation - U.S. FDA approves scent-free prescription nasal inhaled steriod
Seattle Genetics, Inc. - Genetics-focused company gets orphan drug designation for multiple myeloma drug
Siemens Medical Solutions - FDA approves PMA for MAMMOMAT NovationDR
Specialty Laboratories Inc. - Assays to detect Chlamydia and Neisseria gonorrhoeae compared
Swedish Inst. for Infectious Disease Control - Returning travelers could highlight emerging infections worldwide
TriPath Imaging, Inc. - Cancer-focused company submits PMA for HPV test of cervical samples to U.S. FDA
U.S. Food & Drug Administration - Nivalenol induces benign and malignant tumors in mice
Univ. of Texas, Galveston - Scientists find year-round West Nile activity on Gulf Coast
University of Minnesota - Better management of kidney patients may delay need for dialysis
Vaso Active Pharmaceuticals - Pharmaceuticals company, chief executive officer settle with the SEC
West Nile Virus - Donated blood tests positive for West Nile virus
West Nile Virus - Health officials: Don't let your guard down
West Nile Virus - Human case of West Nile virus confirmed in Surry County, North Carolina
West Nile Virus - Michigan's third human case of West Nile confirmed
West Nile Virus - One of Mississippi's first West Nile virus victims fights disease
West Nile Virus - West Nile extends across more of California; death toll hits 11
Return to Top of Page